Dietary Quercetin and Kaempferol: Bioavailability and Potential Cardiovascular-Related Bioactivity in Humans

Short summary

Quercetin and kaempferol glycoside conjugates, particularly glucosides found in onions, show higher bioavailability and potential cardiovascular benefits in humans compared to their aglycone forms, with an optimal dose for lowering blood pressure and inflammation suggested at 500 mg of the aglycone.

AI-generated from the title and abstract; the full text is not read.